Nifty
Sensex
:
:
14677.80
48732.55
-18.70 (-0.13%)
41.75 (0.09%)

Pharmaceuticals & Drugs - Global

Rating :
55/99

BSE: 532331 | NSE: AJANTPHARM

1961.25
14-May-2021
  • Open
  • High
  • Low
  • Previous Close
  •  2009.80
  •  2043.45
  •  1945.10
  •  2005.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  181138
  •  3628.86
  •  2049.00
  •  1331.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 16,958.06
  • 25.93
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 16,798.49
  • 0.66%
  • 5.66

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.34%
  • 0.33%
  • 7.65%
  • FII
  • DII
  • Others
  • 8.37%
  • 11.49%
  • 1.82%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.90
  • 8.34
  • 6.78

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.51
  • 3.08
  • 0.75

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.88
  • 2.39
  • -0.07

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.55
  • 25.04
  • 23.13

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.64
  • 6.24
  • 4.43

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.44
  • 17.20
  • 15.00

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
756.84
681.96
10.98%
748.74
651.21
14.98%
715.91
642.76
11.38%
668.20
611.94
9.19%
Expenses
497.43
530.62
-6.25%
507.06
465.24
8.99%
441.66
465.12
-5.04%
444.98
443.56
0.32%
EBITDA
259.41
151.34
71.41%
241.68
185.97
29.96%
274.25
177.64
54.39%
223.22
168.38
32.57%
EBIDTM
34.28%
14.01%
32.28%
28.56%
38.31%
27.64%
14.01%
14.01%
Other Income
2.53
56.69
-95.54%
5.48
14.64
-62.57%
4.85
13.22
-63.31%
13.12
7.64
71.73%
Interest
2.56
3.62
-29.28%
2.55
1.57
62.42%
1.53
4.93
-68.97%
1.63
1.79
-8.94%
Depreciation
30.60
26.04
17.51%
29.14
23.60
23.47%
28.33
23.30
21.59%
28.02
22.78
23.00%
PBT
228.78
175.86
30.09%
215.47
175.10
23.06%
249.24
161.56
54.27%
206.69
151.45
36.47%
Tax
69.52
46.70
48.87%
38.84
67.55
-42.50%
79.02
45.20
74.82%
58.93
36.82
60.05%
PAT
159.26
129.16
23.30%
176.63
107.55
64.23%
170.22
116.36
46.29%
147.76
114.63
28.90%
PATM
21.04%
7.11%
23.59%
16.52%
23.78%
18.10%
7.11%
7.11%
EPS
18.32
28.29
-35.24%
20.31
12.26
65.66%
19.41
13.27
46.27%
28.29
28.29
0.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
2,889.69
2,587.87
2,055.37
2,125.76
1,983.26
1,733.98
1,473.56
1,208.34
930.84
677.39
498.83
Net Sales Growth
11.66%
25.91%
-3.31%
7.19%
14.38%
17.67%
21.95%
29.81%
37.42%
35.80%
 
Cost Of Goods Sold
5,136.05
537.75
295.72
317.35
322.58
317.33
290.33
283.98
250.11
187.93
153.04
Gross Profit
-2,246.36
2,050.12
1,759.65
1,808.41
1,660.68
1,416.65
1,183.23
924.36
680.73
489.46
345.80
GP Margin
-77.74%
79.22%
85.61%
85.07%
83.73%
81.70%
80.30%
76.50%
73.13%
72.26%
69.32%
Total Expenditure
1,891.13
1,904.54
1,488.94
1,467.37
1,296.38
1,146.92
968.33
839.59
706.35
545.36
409.13
Power & Fuel Cost
-
38.88
32.65
27.42
18.70
15.49
12.91
11.20
10.25
7.83
6.16
% Of Sales
-
1.50%
1.59%
1.29%
0.94%
0.89%
0.88%
0.93%
1.10%
1.16%
1.23%
Employee Cost
-
485.59
430.71
376.47
295.42
256.64
200.58
156.97
123.18
93.84
70.85
% Of Sales
-
18.76%
20.96%
17.71%
14.90%
14.80%
13.61%
12.99%
13.23%
13.85%
14.20%
Manufacturing Exp.
-
204.81
174.78
215.80
192.70
174.40
130.81
96.29
81.76
60.60
40.45
% Of Sales
-
7.91%
8.50%
10.15%
9.72%
10.06%
8.88%
7.97%
8.78%
8.95%
8.11%
General & Admin Exp.
-
159.49
149.90
131.92
92.02
66.24
50.99
47.40
37.02
33.88
24.80
% Of Sales
-
6.16%
7.29%
6.21%
4.64%
3.82%
3.46%
3.92%
3.98%
5.00%
4.97%
Selling & Distn. Exp.
-
413.70
320.99
306.30
270.92
245.92
233.96
201.57
169.99
131.40
90.69
% Of Sales
-
15.99%
15.62%
14.41%
13.66%
14.18%
15.88%
16.68%
18.26%
19.40%
18.18%
Miscellaneous Exp.
-
64.32
84.19
92.11
104.04
70.90
48.75
42.18
34.04
29.88
90.69
% Of Sales
-
2.49%
4.10%
4.33%
5.25%
4.09%
3.31%
3.49%
3.66%
4.41%
4.64%
EBITDA
998.56
683.33
566.43
658.39
686.88
587.06
505.23
368.75
224.49
132.03
89.70
EBITDA Margin
34.56%
26.41%
27.56%
30.97%
34.63%
33.86%
34.29%
30.52%
24.12%
19.49%
17.98%
Other Income
25.98
92.19
21.08
24.16
23.86
21.15
16.80
13.71
5.60
6.22
9.45
Interest
8.27
11.91
1.16
0.41
1.36
4.89
5.92
8.73
19.13
15.43
18.02
Depreciation
116.09
95.72
72.08
59.59
61.21
44.43
51.64
43.88
34.17
31.87
24.75
PBT
900.18
667.89
514.27
622.55
648.17
558.89
464.47
329.85
176.79
90.95
56.39
Tax
246.31
196.27
127.30
153.91
141.34
143.28
146.15
95.97
64.68
13.69
5.67
Tax Rate
27.36%
29.56%
24.75%
24.72%
21.81%
25.64%
32.05%
29.10%
36.59%
15.05%
10.05%
PAT
653.87
467.70
386.97
468.64
506.83
415.61
309.86
233.88
112.11
77.26
50.71
PAT before Minority Interest
653.87
467.70
386.97
468.64
506.83
415.61
309.86
233.88
112.11
77.26
50.71
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
22.63%
18.07%
18.83%
22.05%
25.56%
23.97%
21.03%
19.36%
12.04%
11.41%
10.17%
PAT Growth
39.81%
20.86%
-17.43%
-7.54%
21.95%
34.13%
32.49%
108.62%
45.11%
52.36%
 
EPS
75.59
54.07
44.74
54.18
58.59
48.05
35.82
27.04
12.96
8.93
5.86

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
2,598.87
2,245.21
2,041.37
1,567.69
1,190.86
841.09
593.31
393.43
298.03
228.83
Share Capital
17.54
17.54
17.69
17.69
17.69
17.68
17.67
11.80
11.80
11.80
Total Reserves
2,580.86
2,226.57
2,022.05
1,550.00
1,173.17
822.98
575.06
381.13
286.23
217.03
Non-Current Liabilities
227.61
162.23
38.56
8.90
28.63
55.67
80.62
102.46
100.59
75.64
Secured Loans
0.74
0.66
1.01
1.04
5.79
23.31
41.53
57.57
62.09
48.13
Unsecured Loans
0.00
0.00
0.00
0.00
9.08
9.94
10.77
15.76
14.00
11.42
Long Term Provisions
155.01
134.15
13.16
4.88
2.59
4.76
2.83
2.98
4.91
2.66
Current Liabilities
745.53
498.35
346.05
246.66
259.89
249.59
275.42
222.34
250.19
217.70
Trade Payables
362.34
225.18
249.63
178.18
145.57
109.06
124.54
131.71
101.32
71.19
Other Current Liabilities
180.12
111.45
63.95
46.33
56.72
58.33
47.63
19.45
43.15
29.59
Short Term Borrowings
42.85
33.34
0.00
0.00
46.25
17.90
60.55
51.26
95.27
108.71
Short Term Provisions
160.22
128.38
32.47
22.15
11.35
64.30
42.70
19.92
10.45
8.21
Total Liabilities
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23
648.81
522.17
Net Block
1,462.75
1,168.35
1,052.66
589.17
450.74
288.09
279.39
272.56
246.12
214.03
Gross Block
1,965.22
1,578.96
1,417.23
894.94
715.73
549.85
492.00
438.49
378.01
313.15
Accumulated Depreciation
502.47
410.61
364.57
305.77
264.99
261.76
212.61
165.93
131.89
99.12
Non Current Assets
1,790.94
1,605.27
1,202.36
972.65
716.11
512.94
429.30
349.21
309.13
276.58
Capital Work in Progress
131.86
261.61
61.33
254.22
198.91
170.20
93.55
12.49
2.51
17.22
Non Current Investment
21.67
22.87
7.58
0.00
0.00
40.04
8.46
8.46
8.46
8.46
Long Term Loans & Adv.
167.85
148.36
76.79
41.88
21.29
9.34
39.15
48.61
50.75
33.54
Other Non Current Assets
6.81
4.08
4.00
2.34
4.28
5.27
8.75
7.09
1.29
3.32
Current Assets
1,781.07
1,300.52
1,223.62
850.60
763.27
633.41
520.05
369.02
339.68
245.59
Current Investments
67.14
64.74
182.38
181.56
76.78
19.46
55.00
0.00
0.00
0.00
Inventories
495.68
435.71
350.63
211.02
204.58
159.03
155.40
147.60
167.80
113.12
Sundry Debtors
775.30
459.48
459.79
323.15
372.35
258.76
202.22
150.47
141.00
103.98
Cash & Bank
205.25
100.51
93.09
69.95
43.37
136.76
60.39
46.23
11.48
11.53
Other Current Assets
237.70
96.63
114.62
8.63
66.19
59.40
47.04
24.72
19.40
16.96
Short Term Loans & Adv.
168.68
143.45
23.11
56.29
59.39
47.43
43.66
20.72
15.92
14.41
Net Current Assets
1,035.54
802.17
877.57
603.94
503.38
383.82
244.63
146.68
89.49
27.89
Total Assets
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23
648.81
522.17

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
456.77
374.51
281.12
609.29
326.14
279.42
212.42
234.27
70.35
95.37
PBT
663.97
514.27
622.56
648.17
558.90
456.01
329.85
163.51
90.96
56.39
Adjustment
70.79
61.93
52.48
86.33
53.07
51.21
50.82
65.28
51.35
42.76
Changes in Working Capital
-123.16
-83.46
-254.32
25.88
-124.34
-81.69
-74.52
38.60
-54.53
5.96
Cash after chg. in Working capital
611.60
492.74
420.72
760.38
487.63
425.53
306.15
267.39
87.78
105.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-154.83
-118.23
-139.60
-151.09
-161.49
-146.11
-93.73
-33.12
-17.43
-9.74
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-224.41
-222.78
-256.11
-383.12
-209.07
-158.36
-187.80
-103.70
-53.07
-50.71
Net Fixed Assets
-244.98
-361.08
-327.21
-235.38
-197.00
-138.00
-120.60
-68.66
-46.30
-38.81
Net Investments
-2.28
107.76
-1.82
-104.79
-17.41
2.22
-59.98
-1.81
0.00
0.00
Others
22.85
30.54
72.92
-42.95
5.34
-22.58
-7.22
-33.23
-6.77
-11.90
Cash from Financing Activity
-128.63
-147.46
-0.20
-201.77
-117.32
-105.19
-20.13
-104.49
-12.84
-55.89
Net Cash Inflow / Outflow
103.73
4.27
24.81
24.40
-0.25
15.87
4.49
26.08
4.44
-11.23
Opening Cash & Equivalents
95.16
90.64
65.83
41.42
41.67
38.62
34.13
8.05
3.61
14.84
Closing Cash & Equivalent
198.89
94.91
90.64
65.82
41.42
54.49
38.62
34.13
8.05
3.61

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
297.80
257.19
231.78
178.14
135.31
95.57
67.42
44.73
33.92
26.05
ROA
14.44%
14.52%
22.06%
30.69%
31.66%
29.57%
28.05%
16.40%
13.20%
9.97%
ROE
19.32%
18.07%
25.98%
36.75%
40.92%
43.24%
47.47%
32.46%
29.34%
24.52%
ROCE
27.44%
23.84%
34.49%
45.74%
51.61%
56.43%
54.53%
38.62%
23.23%
17.88%
Fixed Asset Turnover
1.46
1.37
1.84
2.49
2.76
2.85
2.61
2.29
1.98
1.81
Receivable days
87.08
81.62
67.06
63.41
65.84
56.64
52.93
56.78
65.22
72.71
Inventory Days
65.68
69.82
48.10
37.89
37.93
38.64
45.48
61.44
74.79
84.32
Payable days
59.55
63.24
57.26
50.30
41.91
46.38
59.31
61.76
59.93
67.67
Cash Conversion Cycle
93.21
88.21
57.90
51.01
61.86
48.91
39.10
56.46
80.09
89.36
Total Debt/Equity
0.02
0.02
0.00
0.00
0.07
0.09
0.22
0.32
0.67
0.83
Interest Cover
56.75
444.34
1519.41
477.60
115.29
78.03
38.78
10.24
6.89
4.13

News Update:


  • Ajanta Pharma earmarks Rs 250 crore capex for FY22
    10th May 2021, 09:57 AM

    The company is likely to use the same towards maintenance and some new expansions for the corporate office

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.